Equities researchers at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Get Free Report) in a research report issued on Sunday. The brokerage set a “strong-buy” rating on the medical research company’s stock.
Global Cord Blood Stock Performance
NYSE:CO opened at $1.25 on Friday. Global Cord Blood has a 52 week low of $2.03 and a 52 week high of $5.50. The company has a market capitalization of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16. The company has a 50-day moving average of $1.46 and a 200-day moving average of $1.36.
About Global Cord Blood
Featured Articles
- Five stocks we like better than Global Cord Blood
- ESG Stocks, What Investors Should Know
- The 3 Hottest Insiders Buys This Month
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.